NTRK1 and acute myeloid leukemia: As an example, it has been shown that RET, a tyrosine kinase receptor frequently activated in AML, mediates autophagy suppression in a mTORC1 (mammalian target of rapamycin complex1)-dependent way, leading to mutant FLT3 receptor stabilization.